Current Report Filing (8-k)
June 29 2023 - 8:01AM
Edgar (US Regulatory)
0001597892
false
--12-31
CN
0001597892
2023-06-26
2023-06-26
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 26, 2023
JRSIS HEALTH CARE CORPORATION
(Exact name of registrant as specified in its charter)
Florida |
|
1-36758 |
|
46-4562047 |
(State or Other Jurisdiction |
|
(Commission File Number) |
|
(I.R.S. Employer |
of Incorporation) |
|
|
|
Identification No.) |
3/F Building A, Derun Yuan, No. 19 Changyi Road
Wuguishan, Zhongshan City, P.R. China 528458
(Address of Principal Executive Office) (Zip Code)
86-0760-88963658
(Registrant’s telephone number, including
area code)
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
|
|
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.03 Amendments to Articles of Incorporation
On June 26, 2023, the Registrant filed with the
Florida Secretary of State Articles of Amendment to Articles of Incorporation. The Articles of Amendment provide that at 6:30 P.M. Eastern
Time on June 29, 2023 a one-for-ten reverse split of the outstanding common stock will be effective. The Articles of Amendment make no
change to the number of authorized shares of Common Stock. No fractional shares will be issued in connection with the reverse stock split;
any fractional shares that result from the reverse split will be rounded up to the nearest whole share.
The Common Stock will begin trading on a reverse
stock split-adjusted basis on the OTC Pink Market when trading commences on June 30, 2023. The trading symbol for the Common Stock will
remain “JRSS.” The Common Stock was assigned a new CUSIP number (466280203) following the reverse stock split.
The Articles of Amendment also amend the authorized
capital stock by adding two million (2,000,000) shares of Preferred Stock, $0.0001 par value. The Articles authorize the Board of Directors
to designate one or more series of the Preferred Stock, with such voting rights, preferences and other rights as the Board determines.
Item 9.01 Financial Statements and Exhibits
Exhibits
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.
|
JRSIS Health Care Corporation |
|
|
|
Date: June 29, 2023
|
By: |
/s/ Huang Zhifei
|
|
|
Huang Zhifei, Chief Executive Officer |
2
JRSIS Health Care (PK) (USOTC:JRSS)
Historical Stock Chart
From Jul 2024 to Aug 2024
JRSIS Health Care (PK) (USOTC:JRSS)
Historical Stock Chart
From Aug 2023 to Aug 2024